A case of giant cell tumour of the pancreas with a mixture of pleomorphic giant cells and osteoclast-like cells is described. This association is rare and its histogenesis has been debated. The presence of a small differentiated adenocarcinomatous area at the periphery of the tumour indicates an epithelial origin.
Of the non-endocrine tumours of the pancreas, giant cell tumours are rare. Two histopathological types can usually be distinguished.12 The former is described as a pleomorphic giant cell carcinoma. It generally corresponds to an undifferentiated sarcomalike tumour, composed of atypical mononuclear and multinucleated giant cells. Its unfavourable prognosis is similar to that of pancreatic adenocarcinomas.' The second type corresponds to a giant osteoclast-like cell tumour or osteoclastoma, the histopathological pattern of which is similar to skeletal giant cell tumours. ' An abdominal computed tomogram demonstrated a splenic mass in the tail of the pancreas and lateral aortic lymphadenopathies. A large tumour was found on laparotomy, which expanded into the hilum of the spleen, the transverse mesocolon, and the posterior wall of the stomach. No hepatic metastasis was discerned. A distal pancreatectomy, with splenectomy and total gastrectomy "en bloc", was performed.
After a short respite the patient rapidly deteriorated. He died four months later, after a second laparotomy which indicated a peritoneal carcinomatosis. Necropsy was not carried out.
Methods
After fixation in 10% formalin, multiple blocks taken from the tumour were embedded in paraffin wax. For light microscopy, 5 pm sections were stained with haematoxylin and eosin and safran, periodic acid Schiff with diastase digestion, and alcian blue.
An immunohistochemical study using the streptavidin-biotin peroxidase method (Amersham International, Buckinghamshire, England), revealed by 3-amino-9-ethyl-carbazol (Sigma, St Louis, USA), was performed on 5 pm representative paraffin wax embedded sections of the tumour. Antibodies to the following antigens were tested: cytokeratin KL1, epithelial membrane antigen (EMA), vimentin, desmin, actin (Immunotech, Marseille, France), carcino-embryonic antigen (CEA) (Cambridge Research Laboratories), 40-52 kilodaltons keratin, 52-58 kilodaltons keratin (Eurodiagnostic, Ajeldooin, The Netherlands), CD45, lysozyme, a-I antitrypsin, CD68 (KP1), and proliferation cell nuclear antigen (PCNA) PC10 (Dakopatts, Glostrup, Denmark).
Pathological findings
The surgical resection specimen contained a 7 x 5, 5 x 5 cm tumour in the tail of the pancreas. Sections showed a proliferation of non-cohesive pleomorphic cells with numerous giant cells, and exhibited an abundant cytoplasm, occasionally vacuolated, and sometimes faintly stained by alcian blue. They contained an irregular and often polylobulated nucleus with one or several large nucleoli. Numerous mitoses were present. Giant Many multinucleated giant cells which looked like osteoclasts were mixed up with pleomorphic cells (figure). These had a large and intensely stained cytoplasm and contained 10 to 50 small, round, and very regular nuclei, frequently concentrated in a central position.
At the periphery of the lesion, adjacent to the pancreatic parenchyma, and in several pancreatic nodes, differentiated adenocarcinomatous structures were found. There was no mixture of the two tumour patterns.
IMMUNOHISTOCHEMICAL FINDINGS
The pleomorphic cells were variably stained by vimentin and weakly by keratin KL1. The other epithelial markers were negative (EMA, 40-52 and 52-58 kilodaltons). The osteoclast-like cells were not stained by lysozyme and a-I anti-trypsin antibodies. However, these cells strongly expressed CD68, indicating a histiomonocytic origin (figure). Vimentin was weakly expressed. CD45 did not stain and there was no immunohistochemical feature of epithelial differentiation. The adenocarcinoma structures expressed only the epithelial markers and CEA.
In the pleomorphic cells more than 50% of nuclei expressed PCNA, representing intensive proliferative activity. In contrast, nuclei were not stained in the osteoclast-like cells. For osteoclast-like cell tumours, Rosai described some ultrastructural features of epithelial differentiation.4 Other authors have also attributed an epithelial origin from ultrastructural findings,8 but features mentioned in their studies, such as microvilli and desmosome-like junctions, have also been described in some mesenchymal tumours. 7 The authors of the present study believe, as do others,' that the osteoclast-like cells might represent a reactive component of the tumoural stroma.
In the present case, histiomonocytic differentiation of the osteoclast-like cells was shown by the strong expression of CD68. Moreover, the benign cytological results and the lack of PCNA expression are additional arguments in support of a reactive nature for these cells.
The epithelial origin of the tumour is attested by the existence of rare adenocarcinomatous structures. 
